C Treanor1, S Brogan2, Y Burke3, A Curley2, J Galvin3, L McDonagh4, C Murnaghan4, P Mc Donnell5, N O'Reilly6, K Ryan2, H P French4. 1. Physiotherapy Department, Beaumont Hospital, Dublin, Ireland. carolinetreanor@beaumont.ie. 2. Physiotherapy Department, Tallaght University Hospital, Dublin, Ireland. 3. Physiotherapy Department, St James's Hospital, Dublin, Ireland. 4. School of Physiotherapy, Royal College of Surgeons in Ireland, Dublin, Ireland. 5. Physiotherapy Department, Connolly Hospital, Dublin, Ireland. 6. Physiotherapy Department, Beaumont Hospital, Dublin, Ireland.
Abstract
PURPOSE: To determine the predictive validity of the STarT Back tool (SBT) undertaken at baseline and 6 weeks to classify Emergency Department (ED) patients with LBP into groups at low, medium or high risk of persistent disability at 3 months. A secondary aim was to evaluate the clinical effectiveness of pragmatic risk-matched treatment in an ED cohort at 3 months. METHODS: A prospective observational multi-centre study took place in the physiotherapy services linked to the ED in four teaching hospitals in Dublin, Ireland. Patients were stratified into low, medium and high-risk groups at their baseline assessment. Participants received stratified care, where the content of their treatment was matched to their risk profile. Outcomes completed at baseline and 3 months included pain and disability. Linear regression analyses assessed if baseline or 6-week SBT score were predictive of disability at 3 months. Changes in the primary outcome of disability were dichotomised into those who achieved/ did not achieve a 30% improvement in their RMDQ at 6 weeks and 3 months. RESULTS: The study enrolled 118 patients with a primary complaint of LBP ± leg pain with 67 (56.7%) completing their 6-week and 3-month follow-up. Baseline RMDQ and being in medium or high risk SBT group at 6 weeks were predictive of persistent disability at 3 months. A total of 54 (80.6%) participants reported a > 30% improvement at 3 months. CONCLUSION: Disability at baseline and SBT administered at 6 weeks more accurately predicted disability at 3 months than SBT at baseline in an ED population.
PURPOSE: To determine the predictive validity of the STarT Back tool (SBT) undertaken at baseline and 6 weeks to classify Emergency Department (ED) patients with LBP into groups at low, medium or high risk of persistent disability at 3 months. A secondary aim was to evaluate the clinical effectiveness of pragmatic risk-matched treatment in an ED cohort at 3 months. METHODS: A prospective observational multi-centre study took place in the physiotherapy services linked to the ED in four teaching hospitals in Dublin, Ireland. Patients were stratified into low, medium and high-risk groups at their baseline assessment. Participants received stratified care, where the content of their treatment was matched to their risk profile. Outcomes completed at baseline and 3 months included pain and disability. Linear regression analyses assessed if baseline or 6-week SBT score were predictive of disability at 3 months. Changes in the primary outcome of disability were dichotomised into those who achieved/ did not achieve a 30% improvement in their RMDQ at 6 weeks and 3 months. RESULTS: The study enrolled 118 patients with a primary complaint of LBP ± leg pain with 67 (56.7%) completing their 6-week and 3-month follow-up. Baseline RMDQ and being in medium or high risk SBT group at 6 weeks were predictive of persistent disability at 3 months. A total of 54 (80.6%) participants reported a > 30% improvement at 3 months. CONCLUSION: Disability at baseline and SBT administered at 6 weeks more accurately predicted disability at 3 months than SBT at baseline in an ED population.
Authors: Jan Hartvigsen; Mark J Hancock; Alice Kongsted; Quinette Louw; Manuela L Ferreira; Stéphane Genevay; Damian Hoy; Jaro Karppinen; Glenn Pransky; Joachim Sieper; Rob J Smeets; Martin Underwood Journal: Lancet Date: 2018-03-21 Impact factor: 79.321
Authors: Jonathan C Hill; Kate M Dunn; Martyn Lewis; Ricky Mullis; Chris J Main; Nadine E Foster; Elaine M Hay Journal: Arthritis Rheum Date: 2008-05-15
Authors: Euan J McCaughey; Ling Li; Andrew Georgiou; Michael Hg Golding; Johanna I Westbrook Journal: Emerg Med Australas Date: 2016-05-05 Impact factor: 2.151
Authors: Jason M Beneciuk; Mark D Bishop; Julie M Fritz; Michael E Robinson; Nabih R Asal; Anne N Nisenzon; Steven Z George Journal: Phys Ther Date: 2012-11-02
Authors: Benjamin W Friedman; John Conway; Caron Campbell; Polly E Bijur; E John Gallagher Journal: Acad Emerg Med Date: 2018-06-06 Impact factor: 3.451
Authors: Jonathan C Hill; David G T Whitehurst; Martyn Lewis; Stirling Bryan; Kate M Dunn; Nadine E Foster; Kika Konstantinou; Chris J Main; Elizabeth Mason; Simon Somerville; Gail Sowden; Kanchan Vohora; Elaine M Hay Journal: Lancet Date: 2011-09-28 Impact factor: 79.321